Assess the Penumbra System in the Treatment of Acute Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

Also called NCT01429350

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
  • Penumbra Inc. Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01429350
Other papers using this trial's data
  • Impact of Thrombus Length on Outcomes After Intra-Arterial Aspiration Thrombectomy in the THERAPY Trial Stroke, 2017-07 DOI, PubMed 28596447

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01429350. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2020-09-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assess the Penumbra System in the Treatment of Acute Stroke
Acronym
THERAPY
Intervention (Drug)
intravenous (IV) recombinant human tissue plasminogen activator (rtPA)
Intervention (Device)
Penumbra System
Lead sponsor
Penumbra Inc. (class: industry)

Record details

Record id
cardio:ct-nct01429350
Content hash
cba54a9441ebbee24af92f9f72ae69246cc5ce0ccea3532f4d1185a278ec9300